Birmingham Health Partners has announced the launch of its Centre for Regulatory Science and Innovation.
The centre will support the NHS with development of new drug therapies and medical devices, ensuring their safe and effective use with patients.
Bringing together experts in medicinal science, health policy and management, clinical trial design, medical law and patient-reported outcomes research, the centre is a truly multidisciplinary initiative across all BHP organisations, with a single focus: to ensure the quality, safety and efficacy of new medicinal products throughout their lifetime.
Its key research themes include:
- Patient-centred drug development
- AI in healthcare
- Accelerated access to medicines
- Real-world data collection
- Innovative trial design
- Medical technologies
The Centre’s activity is broadly grouped into three pillars: policy development; research and innovation; and capacity building and education. In line with these pillars, CRSI will:
- Generate evidence to support advances in regulation
- Convene national and international debate between key stakeholders
- Provide training and support in regulatory science
- Develop international consensus-based guidance for healthcare in cutting edge disciplines.